Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2019

Authors

  • Suzy M Teutsch Research Fellow, The Australian Paediatric Surveillance Unit; The University of Sydney, Faculty of Medicine and Health, Discipline of Child and Adolescent Health; and The Sydney Children’s Hospitals Network, Westmead, Sydney, New South Wales.
  • Carlos A Nunez Research Associate, The Australian Paediatric Surveillance Unit and The University of Sydney, Faculty of Medicine and Health, Discipline of Child and Adolescent Health and The Sydney Children’s Hospitals Network, Westmead, Sydney, New South Wales.
  • Anne Morris Senior Research Fellow, The Australian Paediatric Surveillance Unit; and Paediatrician and Senior Lecturer, The University of Sydney, Faculty of Medicine and Health, Discipline of Child and Adolescent Health and The Sydney Children’s Hospitals Network, Westmead, Sydney, New South Wales.
  • Robert Booy Senior Professorial Fellow, National Centre for Immunisation Research and Surveillance, Sydney, New South Wales.
  • Skye McGregor Epidemiologist, The Kirby Institute, UNSW Australia, Sydney, New South Wales.
  • Jonathan King Epidemiologist, The Kirby Institute, UNSW Australia, Sydney, New South Wales.
  • Julia M L Brotherton Medical Director, VCS Population Health, VCS Foundation; and Honorary Principal Fellow, Melbourne School of Population and Global Health, University of Melbourne, Victoria.
  • Daniel Novakovic ENT, Head and Neck Surgeon, Laryngologist, and Director, Dr Liang Voice Program, The University of Sydney, Faculty of Medicine and Health, Central Clinical School, Sydney, New South Wales.
  • Cheryl A Jones Dean and Head of Sydney Medical School, The University of Sydney, Faculty of Medicine and Health, Sydney, New South Wales.
  • William Rawlinson Senior Medical Virologist, Director of Serology, Virology and OTDS Laboratories, NSW Health Pathology Randwick, Sydney, New South Wales.
  • Bruce R Thorley Head, National Enterovirus Reference Laboratory and WHO Polio Regional Reference Laboratory, Victorian Infectious Disease Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.
  • Elizabeth J Elliott Professor of Paediatrics and Child Health and Director of The Australian Paediatric Surveillance Unit, The University of Sydney, Faculty of Medicine and Health, Discipline of Child and Adolescent Health and The Sydney Children’s Hospitals Network, Westmead, Sydney, New South Wales.

DOI:

https://doi.org/10.33321/cdi.2020.44.60

Keywords:

Australia, child, public health surveillance, rare diseases, communicable diseases

Abstract

The Australian Paediatric Surveillance Unit (APSU) has been prospectively collecting national data on rare childhood conditions since 1993, with monthly reporting of cases by paediatricians. In this report we describe annual results from studies for ten communicable diseases and complications of communicable diseases that were conducted using APSU surveillance in 2019 and place these in an historic context. Results are reported on acute flaccid paralysis, congenital cytomegalovirus infection, neonatal herpes simplex virus infection, perinatal exposure to HIV, paediatric HIV infection, severe complications of seasonal influenza, juvenile onset recurrent respiratory papillomatosis (JoRRP), congenital rubella syndrome, congenital varicella syndrome and neonatal varicella infection. APSU provides rich clinical data to complement data collected from other surveillance systems and to improve understanding and response to rare childhood infections.

Downloads

Download data is not yet available.

References

Williams K, Elliott E. Role of the Australian Paediatric Surveillance Unit in monitoring communicable diseases of childhood. Commun Dis Intell. 1998;22(13):283–7.

Zurynski YA, Lester-Smith D, Festa MS, Kesson AM, Booy R, Elliott EJ. Enhanced surveillance for serious complications of influenza in children: role of the Australian Paediatric Surveillance Unit. Commun Dis Intell Q Rep. 2008;32(1):71–6.

Owen R, Barr IG, Pengilley A, Liu C, Paterson B, Kaczmarek M. Annual report of the National Influenza Surveillance Scheme, 2007. Commun Dis Intell Q Rep. 2008;32(2):208–26.

He S, Zurynski YA, Elliott EJ. Evaluation of a national resource to identify and study rare diseases: the Australian Paediatric Surveillance Unit. J Paediatr Child Health. 2009;45(9):498–504.

Nunez C, Morris A, Teutsch SM, McGregor S, Brotherton J, Novakovic D et al. Australian Paediatric Surveillance Unit annual report 2018. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.53 .

Australian Institute of Health and Welfare (AIHW). Australia’s children. (Cat. no. CWS 69.) [Internet.] Canberra: Australian Government, AIHW; 2020. [Accessed on 2 April 2020.] Available from: https://www.aihw.gov.au/reports/children-youth/australias-children.

Australian Bureau of Statistics (ABS). 3101.0 - Australian Demographic Statistics, Jun 2019. [Internet.] Canberra: Australian Government, ABS; 2019. Available from: https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%202019?OpenDocument.

Desai S, Smith T, Thorley BR, Grenier D, Dickson N, Altpeter E et al. Performance of acute flaccid paralysis surveillance compared with World Health Organization standards. J Paediatr Child Health. 2015;51(2):209–14.

Roberts J, Hobday L, Ibrahim A, Aitken T, Thorley B. Annual report of the Australian National Enterovirus Reference Laboratory 2014. Commun Dis Intell Q Rep. 2017;41(2):E161–80.

Bao J, Thorley B, Elliott EJ, McIntyre P, Britton PN. Acute flaccid myelitis - has it gone unrecognised in Australian children? Commun Dis Intell (2018). 2020;44. doi: https://doi.org/10.33321/cdi.2020.44.22.

Australian Government Department of Health. Polio Surveillance. [Internet.] Canberra: Australian Government Department of Health; 2019. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-poliomyelitis.htm.

McRae JE, Quinn HE, Saravanos GL, McMinn A, Britton PN, Wood N, et al. Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2016: Prospective hospital-based surveillance for serious paediatric conditions. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.5.

Munro SC, Trincado D, Hall B, Rawlinson WD. Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. J Paediatr Child Health. 2005;41(8):449–52.

McMullan BJ, Palasanthiran P, Jones CA, Hall BM, Robertson PW, Howard J et al. Congenital cytomegalovirus--time to diagnosis, management and clinical sequelae in Australia: opportunities for earlier identification. Med J Aust. 2011;194(12): 625–9.

Bartlett AW, Hall BM, Palasanthiran P, McMullan B, Shand AW, Rawlinson WD. Recognition, treatment and sequelae of congenital cytomegalovirus in Australia: an observational study. J Clin Virol. 2018;108;121–5.

Bartlett AW, McMullan B, Rawlinson WD, Palasanthiran P. Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: a systematic review. Rev Med Virol. 2017. doi: http://doi.org/10.1002/rmv.1938.

Jones CA, Greenow-Raynes C, Isaacs D, on behalf of behalf of the Neonatal HSV Study Investigators and Contributors to the Australian Paediatric Surveillance Unit. Population-based surveillance of neonatal herpes simplex virus infection in Australia, 1997–2011. Clin Infect Dis. 2014;59(4):525–31.

James SH, Kimberlin DW. Neonatal herpes simplex virus infection epidemiology and treatment. Clin Perinatol. 2015;42(1):47–59.

Kimberlin DW, Lin C-Y, Jacobs RF, Powell DA, Frenkel LM, Gruber WC et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108(2):223–9.

Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med. 1991;324(7):444–9.

The Kirby Institute. Annual surveillance report on HIV, viral hepatitis and sexually transmissible infections in Australia 2017. Sydney; University of New South Wales, The Kirby Institute; 2017. Available from: https://kirby.unsw.edu.au/report/annual-surveillance-report-hiv-viral-hepatitis-and-stis-australia-2017.

Deverell M, Phu A, Zurynski YA, Elliott EJ and all chief investigators of APSU surveillance studies. Australian Paediatric Surveillance Unit Annual Report, 2014. Commun Dis Intell Q Rep. 2016;40(2):E216–20.

The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2017. Sydney; University of New South Wales, The Kirby Institute; 2018. Available from: https://kirby.unsw.edu.au/report/hiv-viral-hepatitis-and-sexually-transmissible-infections-australia-annual-surveillance.

Australian Government Department of Health. Eighth National HIV Strategy 2018–2022. Canberra: Australian Government Department of Health; 2018. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-bbvs-1/$File/HIV-Eight-Nat-Strategy-2018-22.pdf.

Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2019. Geneva: United Nations, UNAIDS; 2019. Available from: https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf.

Louie JK, Schechter R, Honarmand S, Guevara HF, Shoemaker TR, Madrigal NY et al. Severe pediatric influenza in California, 2003–2005: implications for immunization recommendations. Pediatrics. 2006;117(4):e610–8.

Australian Government Department of Health. Australian influenza surveillance report no. 12 – 23 September to 06 October 2019. Canberra: Australian Government Department of Health; 2019. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/ozflu-surveil-no12-19.htm#current.

Donne AJ, Clarke R. Recurrent respiratory papillomatosis: an uncommon but potentially devastating effect of human papillomavirus in children. Int J STD AIDS. 2010;21(6):381–5.

Tjon Pian Gi REA, San Giorgi MRM, Slagter-Menkema L, van Hemel BM, van der Laan BFAM, van den Heuvel ER et al. Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. Head Neck. 2015;37(11):1625–32.

Novakovic D, Cheng ATL, Zurynski Y, Booy R, Walker PJ, Berkowtz R et al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018; 217(2):208–12.

Machalek DA, Garland SM, Brotherton JML, Bateson D, McNamee K, Stewart M et al. Very low prevalence of vaccine human papillomavirus types among 18- to 35-Year old Australian women 9 years following implementation of vaccination. J Infect Dis. 2018;217(10):1590–600.

Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ. 2013;346:f2032. doi: https://doi.org/10.1136/bmj.f2032.

Khandaker G, Zurynski Y, Jones C. Surveillance for congenital rubella in Australia since 1993: cases reported between 2004 and 2013. Vaccine. 2014;32(50):6746–51.

Martin N, Durrheim D, Khandaker G, Butler M, Jones C. Using the two-source capture-recapture method to estimate the incidence and case ascertainment of congenital rubella syndrome in Australia, 1993–2013. Western Pac Surveill Response J. 2016;7(1):34–7.

Deverell M, Phu A, Zurynski YA, Elliott EJ and all chief investigators of Australian Paediatric Surveillance Unit surveillance studies. Australian Paediatric Surveillance Unit annual report, 2015. Commun Dis Intell Q Rep. 2017;41(2):E181–5.

Hull B, Hendry A, Dey A, Brotherton J, Macartney K, Beard F. Annual immunisation coverage report 2017. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.47.

Forrest J, Mego S, Burgess M. Congenital and neonatal varicella in Australia. J Paediatr Child Health. 2000;36(2);108–13.

Khandaker G, Marshall H, Peadon E, Zurynski Y, Burgner D, Buttery J et al. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Arch Dis Child. 2011;96(5),453–6.

Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. [Internet.] Canberra: Australian Government Department of Health, ATAGI; 2018. Available from: https://immunisationhandbook.health.gov.au/.

Beard FH, Hendry AJ, Macartney K. Early success with room for improvement: influenza vaccination of young Australian children. MJA 2019;210(11),484-6.

National Centre for Immunisation Research and Surveillance (NCIRS). Significant events in influenza vaccination practice in Australia. Sydney: Sydney Children’s Hospitals Network, NCIRS; 2018. Available from: http://www.ncirs.org.au/sites/default/files/2018-11/Influenza-history-July-2018.pdf.

Downloads

Published

17/08/20

How to Cite

Teutsch, Suzy M, Carlos A Nunez, Anne Morris, Robert Booy, Skye McGregor, Jonathan King, Julia M L Brotherton, et al. 2020. “Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2019”. Communicable Diseases Intelligence 44 (August). https://doi.org/10.33321/cdi.2020.44.60.

Issue

Vol. 44 (2020)

Section

Annual report

Categories

License

Copyright (c) 2023 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 5 > >>